Days
Hours
Minutes
Seconds
-40%
on all subscriptions*
Exceptional extension!
Enjoy this offer
* See conditions under "Our services"

Valuation: RaySearch Laboratories AB

Market Cap 7.1B 731M 642M 592M 554M 1.04B 69.23B 1.06B 2.75B 33.97B 2.74B 2.68B 118B P/E 2026 *
24.9x
P/E 2027 * 20x
Enterprise Value 7.01B 722M 634M 584M 547M 1.02B 68.35B 1.04B 2.71B 33.54B 2.71B 2.65B 117B EV / Sales 2026 *
4.98x
EV / Sales 2027 * 4.27x
Free-Float
80.09%
Yield 2026 *
1.93%
Yield 2027 * 2.5%
1 day+0.05%
1 week-3.63%
Current month-5.65%
1 month-1.71%
3 months+14.10%
6 months-7.91%
Current year-9.12%
1 week 203.2
Extreme 203.2
220.2
1 month 203.2
Extreme 203.2
227.6
Current year 166.8
Extreme 166.8
237.2
1 year 166.8
Extreme 166.8
373.5
3 years 55.6
Extreme 55.6
373.5
5 years 40
Extreme 40
373.5
10 years 40
Extreme 40
373.5
Manager TitleAgeSince
Chief Executive Officer 57 01/01/2000
Director of Finance/CFO 48 27/01/2025
Chief Tech/Sci/R&D Officer 53 28/08/2015
Director TitleAgeSince
Director/Board Member 57 01/01/2000
Chairman 81 18/11/2016
Chairman 87 30/09/2022
Date Insider Type Main position Quantity % Market Cap.
11/06Buy 1,848 0.0060%
11/06Buy 1,386 0.0045%
11/06Buy

Executive/Senior Manager

2,310 0.0075%
Change 5-day change 1-year change 3-year change Capi.($)
-0.67%-3.63%-34.12%+232.05% 745M
+4.28%-2.25%-43.02%-20.45% 24.88B
-0.98%+5.09%-37.53%+158.03% 12.79B
+2.55%-3.76%-10.39%+55.44% 5.5B
+1.89%+7.58% - - 2.92B
-2.89%+15.41% - - 2.04B
-0.70%-3.73%+35.39%-45.21% 1.76B
-1.39%-5.07%-22.01% - 1.27B
+0.29%-2.82%-31.82%-60.97% 787M
-6.74%-20.83%-51.15%-67.15% 595M
Average -0.45%-2.05%-24.33%+35.96% 5.33B
Weighted average by Cap. +1.55%-1.47%-34.23%+38.73%

Financials

2026 *2027 *
Net sales 1.41B 145M 127M 117M 110M 206M 13.73B 209M 545M 6.74B 544M 532M 23.42B 1.6B 165M 145M 134M 125M 234M 15.62B 238M 621M 7.67B 619M 606M 26.64B
Net income 285M 29.32M 25.76M 23.74M 22.22M 41.63M 2.78B 42.33M 110M 1.36B 110M 108M 4.74B 355M 36.52M 32.09M 29.57M 27.68M 51.86M 3.46B 52.73M 137M 1.7B 137M 134M 5.9B
Net Debt -90M -9.26M -8.13M -7.5M -7.02M -13.15M -877M -13.37M -34.84M -430M -34.76M -34.01M -1.5B -265M -27.26M -23.95M -22.07M -20.66M -38.71M -2.58B -39.36M -103M -1.27B -102M -100M -4.4B
Logo RaySearch Laboratories AB
RaySearch Laboratories AB (publ) is a Sweden-based medical technology company that develops software for radiation therapy of cancer. It markets and sells its products mainly in the United States and in Europe through license agreements with medical technology companies and scientific institutions. Additionally, its solutions include software for optimizing Intensity Modulated Radiation Therapy (IMRT) plans for photons, adaptive technology for IMRT treatments and software for proton treatments. The Company’s commercial partners are Philips, Nucletron and IBA Dosimetry, among others. In April 2014, it established a German subsidiary, RaySearch Germany GmbH.
Employees
465
Date Price Change Volume
24/06/26 SEK 207.20 -0.67% 208,030
22/06/26 SEK 208.60 +0.29% 152,369
18/06/26 SEK 208.00 -1.14% 269,000
17/06/26 SEK 210.40 -2.68% 127,151
16/06/26 SEK 216.20 +0.56% 159,352
Trader
Investor
Global
Quality
ESG MSCI
B
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
1
Last Close Price
208.60SEK
Average target price
330.00SEK
Spread / Average Target
+58.20%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. RAY B Stock
-40%: Exceptional extension
d
:
:
SEIZE THE OFFER!